FindTrial
Sign In

Cohort study of immune prevention of Patients with Liver Cancer

Study on immune prevention of PLC in etiology

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ECH-12002805
Enrollment
Unknown
Registered
2012-12-07
Start date
1983-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatitis B, cirrhosis, HCC

Interventions

vaccination group:receive HB vaccine

Sponsors

Qidong Liver Cancer Institute
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 1 Years

Inclusion criteria

Inclusion criteria: the newborn from Oct.1983 to Dec.1990, and born in the immuno-town random in Qidong

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

MeasureTime frame
HBsAg;anti-HBs;ALT;anti-HBe;—

Countries

China

Contacts

Public ContactTaoyang Chen
ty110@263.net+86 0513 83106001

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026